Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IMIPENEM Cause Multiple organ dysfunction syndrome? 80 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Multiple organ dysfunction syndrome have been filed in association with IMIPENEM. This represents 4.3% of all adverse event reports for IMIPENEM.

80
Reports of Multiple organ dysfunction syndrome with IMIPENEM
4.3%
of all IMIPENEM reports
63
Deaths
35
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From IMIPENEM?

Of the 80 reports, 63 (78.8%) resulted in death, 35 (43.8%) required hospitalization, and 7 (8.8%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IMIPENEM. However, 80 reports have been filed with the FAERS database.

What Other Side Effects Does IMIPENEM Cause?

Drug ineffective (351) Off label use (202) Condition aggravated (138) Vomiting (137) Drug resistance (117) Nausea (111) Dyspnoea (97) Diarrhoea (90) Pyrexia (90) Product use in unapproved indication (85)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which IMIPENEM Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

IMIPENEM vs IMIPRAMINE IMIPENEM vs IMIQUIMOD IMIPENEM vs IMITREX IMIPENEM vs IMMUNE GLOBULIN NOS IMIPENEM vs IMPLANON

Related Pages

IMIPENEM Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome IMIPENEM Demographics